What You Should Know
- Headlamp Health has launched Lumos AI, an analytical decision-support layer specifically engineered to solve the "Complexity Gap" in neuroscience drug development.
- Unlike tools focused on trial logistics, Lumos AI utilizes longitudinal real-world data and clinical logic to identify patient subtypes most likely to respond to a therapy, aiming to bring the precision-based success of oncology to the field of psychiatry.
The Failure of ‘One-Size-Fits-All’
Read More
Utah Becomes First State to Approve AI System for Prescription Renewals
What You Should Know
- The Utah Department of Commerce has officially authorized Doctronic to become the first AI system in the U.S. to legally participate in medical decision-making for prescription renewals.
- Operating under Utah’s "Regulatory Sandbox" framework, the pilot aims to address the $100 billion in avoidable medical expenses caused annually by medication non-compliance, specifically targeting the 80% of medication activity that involves routine refills.
The
Read More
Why Tegria’s Exit from Providence Reshapes Health IT Outsourcing
What You Should Know
- Providence St. Joseph Health has officially offloaded Tegria Services Group to private equity firm Altaris, marking the end of a high-profile experiment in health system-owned IT consulting.
- This move decouples Tegria from its non-profit roots, handing the reigns to a PE player with $9B in assets and a mandate to scale Tegria’s MEDITECH and Epic optimization services across a fragmented market.
The Post-Captive Pivot: Can Tegria Compete Without a Safety
Read More
Who Made Your Medicine? How to Use ProPublica’s Rx Inspector to Audit Your Generics
What You Should Know
- ProPublica has released Rx Inspector, a first-of-its-kind database that allows Americans to identify the exact facility where their generic prescriptions were manufactured.
- By connecting disparate FDA databases and suing for factory location data, ProPublica has mapped more than 80% of generic products to their originating plants, revealing safety violations that the FDA has historically kept hidden from consumers.
The Shadow World of Generic
Read More
The Agentic Era: Why Glen Tullman is Killing the Healthcare Chatbot in 2026
What You Should Know
- Transcarent has officially launched WayFinding 2.0, marking a strategic shift from the "chat assistant era" to the "agentic action era" in healthcare.
- By integrating autonomous AI agents that can schedule appointments, triage symptoms, and manage follow-ups via a proprietary Total Recall Memory Engine, the platform aims to eliminate the chronic administrative friction that currently defines the American healthcare experience.
The Death of the Chatbot: Entering
Read More
The Standard of Care Shift: Heartflow Secures Nationwide Aetna Coverage for AI Plaque Analysis
What You Should Know
- Heartflow has achieved a major milestone as Aetna updates its policies to cover AI-driven Heartflow Plaque Analysis across all lines of business, effective December 23, 2025.
- This move, combined with the new Category I CPT code 75577, provides a clear reimbursement pathway for the first time, establishing 4.00 total RVUs for the service and ensuring that AI-enabled plaque quantification is no longer a "pilot" technology but a standard of care.
The
Read More
KLAS Healthcare IoT Security 2026: Top Vendors Rated for Risk Reduction and ROI
What You Should Know:
A new 2026 report from KLAS Research signals a major shift in the healthcare IoT security market: hospitals are no longer satisfied with just "seeing" their devices—they demand measurable risk reduction. The report names Asimily and Claroty as the market leaders with the highest energy, driven by their ability to deliver tangible outcomes like automated remediation and strong segmentation. Conversely, legacy players are facing scrutiny over complexity and training
Read More
The EEG as a ‘Vital Sign’: Ceribell’s AI Pivot to In-Hospital Stroke Detection
What You Should Know:
- Ceribell’s LVO Stroke Breakthrough In January 2026, the FDA granted Breakthrough Device Designation to Ceribell for its LVO (Large Vessel Occlusion) stroke monitor.
- This first-in-class tool applies an AI algorithm to portable EEG hardware to detect in-hospital strokes—which account for 17% of all strokes and have a mortality rate 3x higher than community-onset strokes. By providing continuous bedside monitoring, it aims to eliminate the "detection gap"
Read More
AMA’s Strategic Push for Permanent Medicare Telehealth Reform
What You Should Know
- The AMA is urging Congress to pass permanent authorization of Medicare telehealth services before the current waiver expires on January 30, 2026.
- This advocacy follows a "tumultuous" 2025 in which a 43-day government shutdown caused a 24% national drop in fee-for-service telemedicine visits, demonstrating the extreme sensitivity of patient access to legislative lapses.
The Economic Battle: Challenging CBO Scoring
The crux of the AMA’s issue brief is a
Read More
Avoiding the Telemedicine Cliff: Why the DEA Extended Prescribing Rules Through 2026
What You Should Know:
- In a significant move for the "tele-prescribing" landscape, the U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have announced a fourth temporary extension of telemedicine flexibilities.
- This extension allows practitioners to prescribe controlled medications—including Schedule II–V drugs—via audio-video encounters without a prior in-person medical evaluation through December 31, 2026.
A Transitional
Read More
